LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain cancer known for its fast growth and insensitivity to standard treatments. Investigations are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is highly expressed in GBM cell